Published date: 19 June 2020

Awarded contract - This means that the contract has been awarded to a supplier.


Closing: 1 June 2020

Contract summary

Industry

  • Health and social work services - 85000000

Location of contract

Any region

Value of contract

£164,550

Procurement reference

tender_241204/863066

Published date

19 June 2020

Closing date

1 June 2020

Contract start date

3 June 2020

Contract end date

30 June 2020

Contract type

Service contract

Procedure type

Restricted procedure (above threshold)

A two-stage procedure, where the first stage is used to select suppliers, who are then invited to bid in the second stage.

This procedure can be used for procurements above the relevant contract value threshold.

Contract is suitable for SMEs?

Yes

Contract is suitable for VCSEs?

Yes

Description

A framework that will inform recommendations to ministers on the procurement and manufacture of drugs for the treatment of COVID-19, potentially incurring significant expenditure at risk. This decision-making framework will be used alongside the clinical expertise already available to the department such as the Chief Medical Officer (CMO) and Deputy Chief Medical Officer's (DCMO) assessment of treatments data.

More information

Attachments

Award information

Awarded date

3 June 2020

Contract start date

3 June 2020

Contract end date

30 June 2020

Total value of contract

£164,550

This contract was awarded to 1 supplier.

Oliver Wyman

Address

55 Baker Street, London, Greater London, W1U 8EW , UNITED KINGDOM

Reference

No reference - other

Supplier is SME?

No

Supplier is VCSE?

No

About the buyer

Contact name

Martin Hartley

Address

39 Victoria Street
London
SW1H 0EU
England

Telephone

0

Email

martin.hartley@dhsc.gov.uk

Website

www.gov.uk/government/organisations/department-of-health-and-social-care